• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • NeuroSTAT Project Receives FDA Fast Track Designation americanpharmaceuticalreview
    July 30, 2019
    NeuroVive announced the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the US Food and Drug Administration ...
  • NeuroVive to continue NeuroSTAT clinical development pharmaasia
    June 06, 2017
    The positive outcome from the clinical phase IIa CHIC study and the preclinical studies have now convinced NeuroVive to proceed into the next stage of clinical development.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service